A synthetic peptide for use as a blocking control in assays to test for specificity of FLII antibody, Alternative Names: FLII control peptide, FLII antibody Blocking Peptide, Anti-FLII Blocking Peptide, Flightless I Homolog Blocking Peptide, FLI Blocking Peptide, FLIL Blocking Peptide, Fli1 Blocking Peptide, MGC39265 Blocking Peptide
FLII
Reaktivität: Human
Wirt: Synthetic
BP, WB, IHC
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
FLII
(Flightless I Homolog (FLII))
Hintergrund
FLII is a protein with a gelsolin-like actin binding domain and an N-terminal leucine-rich repeat-protein protein interaction domain. The protein is similar to a Drosophila protein involved in early embryogenesis and the structural organization of indirect flight muscle. This gene is located within the Smith-Magenis syndrome region on chromosome 17.